Taghoy, Eddie T.

HRN: 21-47-28  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
CEFIXIME 200MG (CAP)
06/27/2022
07/03/2022
PO
200mg
BID
DM Foot
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: